Ipsen Sa Adr (OTCMKTS:IPSEY) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Friday.
According to Zacks, “Ipsen S.A. is a pharmaceutical company. It provide drugs for urology, oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology and cardiovascular. Ipsen S.A. is headquartered in Boulogne-Billancourt, France. “
Ipsen Sa Adr (OTCMKTS:IPSEY) traded up 3.81% on Friday, reaching $33.61. 2,705 shares of the company’s stock were exchanged. The firm has a market cap of $11.08 billion and a PE ratio of 44.24. The firm’s 50-day moving average is $30.89 and its 200-day moving average is $23.63. Ipsen Sa Adr has a 12 month low of $14.15 and a 12 month high of $33.81.
WARNING: This report was first published by WKRB News and is owned by of WKRB News. If you are reading this report on another site, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this report can be viewed at https://www.wkrb13.com/markets/2229330/ipsen-sa-adr-ipsey-downgraded-by-zacks-investment-research-to-hold.html.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2229330/ipsen-sa-adr-ipsey-downgraded-by-zacks-investment-research-to-hold.html
Receive News & Ratings for Ipsen Sa Adr Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ipsen Sa Adr and related companies with MarketBeat.com's FREE daily email newsletter.